Compare ETFs
Fees, size, distributions, currency exposure and holdings overlap for two to four funds, side by side.
Side by side
| Measure | BBPVirtus Biotech ETF | VTVanguard Total World Stock Index ETF |
|---|---|---|
| Market | USNYSE Arca | USNYSE Arca |
| Issuer | Virtus | Vanguard |
| Asset class | Equity · Global | Equity · Global |
| Expense ratio | 0.34%Expense ratio, filed 27 Feb 2026 | 0.06%Expense ratio, filed 27 Feb 2026 |
| Net assets | $98.5MAs of 31 Jul 2026 | $97.9BAs of 31 Jul 2026 |
| Holdings | 70As of 31 Jul 2026 | 10,100As of 31 Jul 2026 |
| 12-month distribution yield | No trailing yield | 1.53% |
| Distributions | None in 12 months | Quarterly$2.4130 in 12 months |
| Last price | $104.8820 Oct 2026, 14:51 UTC | $157.8020 Oct 2026, 20:00 UTC |
Holdings overlap
Weighted overlap is the sum, over the securities both funds hold, of the smaller of the two weights. 0% means no shared holdings; 100% means identical portfolios.
| Fund | BBP | VT |
|---|---|---|
| BBP | Same fund | 0.8%at least |
| VT | 0.8%at least | Same fund |
BBP and VT
- Weighted overlap
- 0.8%
- Holdings in common
- 25
- BBP holdings also in VT
- 37.3% by count
- VT holdings also in BBP
- 1.3% by count
| Holding | Weight in BBP | Weight in VT | Overlap | Matched by |
|---|---|---|---|---|
| AMGEN INCAMGEN INC COM US0311621009 | 1.49% | 0.18% | 0.18% | ISIN |
| GILEAD SCIENCES INC US3755581036 | 1.43% | 0.14% | 0.14% | ISIN |
| VERTEX PHARMACEUTICALS INC US92532F1003 | 1.48% | 0.10% | 0.10% | ISIN |
| REGENERON PHARMACEUTICALSREGENERON PHARMACEUTICALS INC US75886F1075 | 1.72% | 0.07% | 0.07% | ISIN |
| BIOGEN INC US09062X1037 | 1.40% | 0.03% | 0.03% | ISIN |
| ALNYLAM PHARMACEUTICALS INCALNYLAM PHARMACEUTICALS INC COM US02043Q1076 | 1.00% | 0.02% | 0.02% | ISIN |
| UNITED THERAPEUTICS CORP US91307C1027 | 1.31% | 0.02% | 0.02% | ISIN |
| INSMED INCINSMED INC COM PAR $.01 US4576693075 | 1.39% | 0.02% | 0.02% | ISIN |
| INCYTE CORP US45337C1027 | 1.52% | 0.02% | 0.02% | ISIN |
| MODERNA INCMODERNA INC COM US60770K1079 | 1.51% | 0.02% | 0.02% | ISIN |
How overlap is measured
Each fund's latest public Form N-PORT report lists its positions with the percent of net assets each one makes up. For every security both funds hold, the smaller of its two weights is counted, and those are added up. If fund A holds a stock at 6% and fund B at 4%, that stock adds 4 percentage points.
Securities are matched by ISIN first, then by CUSIP (a US or Canadian ISIN contains the CUSIP), and only as a last resort by issuer name, for non-debt holdings where one fund gives no identifier. Repeated lines of the same security in one fund are added together, and each security is matched once.
Cash funds, repurchase agreements, derivative contracts and short positions are left out because their reported value is not comparable exposure. For funds with more than 2,000 positions only the largest 2,000 are stored, so the result is a lower bound and the possible extra is shown. Reports can be for different month ends, and funds trade between reports.
The count-based shares show how many of one fund's holdings the other also holds, which can be high even when overlap by weight is low. Read more in where the ETF data comes from.
Currency exposure
| Currency | BBP | VT |
|---|---|---|
| US dollar (USD) | 100.5% | 62.9% |
| Euro (EUR) | Below the top 12 or none | 7.3% |
| Japanese yen (JPY) | Below the top 12 or none | 5.8% |
| British pound (GBP) | Below the top 12 or none | 3.2% |
| New Taiwan dollar (TWD) | Below the top 12 or none | 3.1% |
| Canadian dollar (CAD) | Below the top 12 or none | 3.0% |
| Hong Kong dollar (HKD) | Below the top 12 or none | 2.4% |
| South Korean won (KRW) | Below the top 12 or none | 2.2% |
| Swiss franc (CHF) | Below the top 12 or none | 2.0% |
| Indian rupee (INR) | Below the top 12 or none | 1.7% |